Fox Business - The Power to Prosper
Search Site

Allergan

Investing for the New Year

S&P Capital IQ Senior Director Rich Peterson, Veracruz Founder Steve Cortes and Morgan Creek Capital Management CEO Mark Yusko discuss how to prepare your portfolio for 2015.

Read More

  1. Allergan in talks to buy Salix

    Wall Street Journal reporters David Benoit and Liz Hoffman on Allergan ’s efforts to buy Salix to ward off Valeant’s hostile bid.

  2. Shooter Jennings sings ‘She Thinks I Still Care’

    Musician Shooter Jennings sings ‘She Thinks I Still Care’ on Imus.

  3. The inversion play

    FBN’s Liz MacDonald on hedge funds’ inversion push.

  4. Allergan ’s top shareholder sells majority stake

    FBN’s Liz MacDonald on one of Allergan ’s largest shareholder selling its’ stake amid a takeover bid from Valeant.

  5. Allergan 2Q earnings beat expectations

    Earnings HQ: FBN’s Lori Rothman breaks down Allergan ’s second-quarter earnings report.

  6. What is behind the success of specialty pharma?

    Sanford Bernstein analyst Ronny Gal on the business model of specialty pharma.

  7. What is behind the success of specialty pharma?

    Sanford Bernstein analyst Ronny Gal on the business model of specialty pharma.

  8. Allergan : Back off, Ackman

    Wall Street Journal reporter David Benoit and FOX Business contributor Bob Rice on Allergan looking to potential acquisitions to fend off activist investor Bill Ackman.

  9. Paulson acquiring 6M Allergan shares

    Liz Hoffman of the Wall Street Journal on hedge-fund manager John Paulson’s latest strategy.

  10. Valeant goes hostile

    FBN’s Liz MacDonald on Valeant’s hostile bid in its offer for Allergan .

  11. Trouble brewing at Valeant?

    FBN’s Liz MacDonald says Wall Street is talking about Valeant’s bad-balance sheet.

  12. Barra faces shareholders

    FBN’s Maria Bartiromo breaks down what you need to know.

  1. A great year for M&A

    Dana Mattioli of The Wall Street Journal discusses 2014 M&A volume.

  2. 86M unemployed Americans don’t want a job?

    Capitalistpig Asset Management’s Jonathan Hoenig and FBN’s Liz MacDonald and Tracy Byrnes on the number of unemployed Americans who do not want to work and the record M&A activity.

  3. Inside the Allergan , Actavis deal

    Wall Street Journal Reporter David Benoit weighs in on the $66 billion deal for Activis to acquire Allergan .

  4. Ackman makes $2B bet on animal health

    David Benoit and Liz Hoffman of The Wall Street Journal on activist investor Bill Ackman’s new stake in animal health company Zoetis.

  5. Salix’s market-cap vaporizing

    FBN’s Liz MacDonald on Salix shares dropping.

  6. Darden investors elect full Starboard slate

    Christopher Davis of Kleinberg Kaplan and David Benoit of The Wall Street Journal discuss Starboards victory in replacing Darden’s board.

  7. Ackman threatens to sue Allergan over Salix deal

    David Benoit of The Wall Street Journal breaks down the latest on the fight to take over Allergan .

‹ Prev12345Next ›
Freebase CC-BY
Source: Allergan on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL